0001193125-11-088464.txt : 20110405 0001193125-11-088464.hdr.sgml : 20110405 20110404204542 ACCESSION NUMBER: 0001193125-11-088464 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110405 DATE AS OF CHANGE: 20110404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALDAGEN INC CENTRAL INDEX KEY: 0001128188 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 562185054 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-162700 FILM NUMBER: 11737991 BUSINESS ADDRESS: STREET 1: 2810 MERIDIAN PARKWAY SUITE 148 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-484-2571 MAIL ADDRESS: STREET 1: 2810 MERIDIAN PARKWAY SUITE 148 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: STEMCO BIOMEDICAL INC DATE OF NAME CHANGE: 20001114 RW 1 drw.htm FORM RW Form RW

ALDAGEN, INC.

2810 Meridian Parkway

Suite 148

Durham, NC 27713

April 4, 2011

VIA EDGAR AND FEDERAL EXPRESS

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re: Aldagen, Inc.

Registration Statement on Form S-1

Registration No. 333-162700

Ladies and Gentlemen:

Aldagen, Inc. (the “Company”), pursuant to Rule 477(a) promulgated under the Securities Act of 1933, as amended, hereby requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal of the Company’s Registration Statement on Form S-1 (File No. 333-162700), together with all amendments and exhibits thereto (the “Registration Statement”), effective as of the date hereof. The Company does not intend to conduct the offering of shares of common stock contemplated in the Registration Statement due to market conditions and its determination that registration of the Company’s securities is not in the best interest of the Company at this time. No shares of common stock of the Company have been or will be issued or sold under the Registration Statement.

Accordingly, we request an order granting the withdrawal of the Registration Statement to be issued by the Commission as soon as possible. Please provide a copy of the order granting the withdrawal of the Registration Statement to the undersigned via facsimile at (919) 484-8792, with a copy to Fred D. Hutchison of Hutchison Law Group, the Company’s counsel, via facsimile at (919) 829-9696.

Pursuant to Rule 477(c), the Company advises the Commission that the Company may undertake a subsequent private offering in reliance on Rule 155(c) promulgated under the Act.

If you have any questions or require further information regarding this application of withdrawal of the Registration Statement, please do not hesitate to call Fred Hutchison of Hutchison Law Group at (919) 829-4300.

 

Sincerely,
ALDAGEN, INC.
By:   /s/ Lyle Hohnke
 

Lyle Hohnke

Chief Executive Officer